2022
Exports | Imports
$1.62M | $722MWorld Rnk 101 / 208
Flag Rnk 553 / 1127
World Rnk 46 / 225
Flag Rnk 44 / 1201
2022
ECONOMIC COMPLEXITY of Philippines
0.63Rnk 38 / 124
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.47Rnk 46 / 1025

About

Exports In 2022, Philippines exported $1.62M in Vaccines, blood, antisera, toxins and cultures, making it the 101st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 553rd most exported product in Philippines. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Philippines are: Singapore ($827k), Hong Kong ($461k), South Korea ($70.9k), China ($59.7k), and Ireland ($33.7k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Philippines between 2021 and 2022 were Singapore ($810k), China ($57.5k), and Panama ($29.3k).

Imports In 2022, Philippines imported $722M in Vaccines, blood, antisera, toxins and cultures, becoming the 46th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 44th most imported product in Philippines. Philippines imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($177M), Belgium ($109M), Germany ($87.8M), France ($58.8M), and Spain ($53.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Philippines between 2021 and 2022 were Spain ($42.5M), Netherlands ($10.4M), and India ($4.33M).

COMPANIES In 2020, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Philippines to the United States.

Latest Trends

August 2021

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (August 2020 - August 2021)$-2.36k(-31.3%)
IMPORT GROWTH (August 2020 - August 2021)$132M(577%)
MAIN DESTINATION (August 2021)Cambodia$4.24k

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Philippines. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$1.62M
IMPORTS (2022)$722M
NET TRADE (2022)-$720M

In 2022, Philippines exported $1.62M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Philippines exports on Vaccines, blood, antisera, toxins and cultures were Singapore ($827k), Hong Kong ($461k), South Korea ($70.9k), China ($59.7k), and Ireland ($33.7k).

In 2022, Philippines imported $722M in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($177M), Belgium ($109M), Germany ($87.8M), France ($58.8M), and Spain ($53.6M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Philippines WERE (2021 - 2022):
Singapore$810k (4.58k%)
China$57.5k (2.71k%)
Panama$29.3k (1%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Philippines WERE (2021 - 2022):
Netherlands-$306k (-96%)
Vietnam-$144k (-89.3%)
Papua New Guinea-$41.2k (-100%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Philippines's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Philippines's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with